A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia
The Journal of Reproductive Medicine,  Clinical Article

Shah NT et al. – Based on similar efficacy and lower societal cost, authors recommend 8–day MTX/folinic acid for first–line treatment of low–risk gestational trophoblastic neoplasia (GTN).

Methods
  • A decision tree of the 3 most commonly used first–line low–risk GTN treatment strategies was created, accounting for toxicities, response rates and need for second– or third–line therapy.
  • These strategies included 8–day methotrexate (MTX)/folinic acid, weekly MTX, and pulsed actinomycin–D (act–D).
  • Response rates, average number of cycles needed for remission, and toxicities were determined by review of the literature.
  • Costs of each strategy were examined from a societal perspective, including the direct total treatment costs as well as the indirect lost labor production costs from work absences.
  • Sensitivity analysis on these costs was performed using both deterministic and probabilistic cost–minimization models with the aid of decision tree software (TreeAge Pro 2011, TreeAge Inc., Williamstown, Massachusetts).

Results
  • They found that 8–day MTX/folinic acid is the least expensive to society, followed by pulsed act–D ($4,867 vs. $6,111 average societal cost per cure, respectively), with act–D becoming more favorable only with act–D per–cycle cost <$231, or response rate to first–line therapy >99%.
  • Weekly MTX is the most expensive first–line treatment strategy to society ($9,089 average cost per cure), despite being least expensive to administer per cycle, based on lower first–line response rate.
  • Absolute societal cost of each strategy is driven by the probability of needing expensive third–line multiagent chemotherapy, however relative cost differences are robust to sensitivity analysis over the reported range of cycle number and response rate for all therapies.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Obstetrics & Gynecology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Obstetrics & Gynecology Articles

1 A revised birth weight reference for the United States Obstetrics and Gynecology, July 14, 2014    Clinical Article

2 Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: A randomized controlled trial American Journal of Clinical Nutrition, July 17, 2014    Clinical Article

3 Metformin in reproductive health, pregnancy and gynaecological cancer: Established and emerging indications Human Reproduction Update, July 24, 2014    Review Article

4 First trimester coffee and tea intake and risk of gestational diabetes mellitus: A study within a national birth cohort BJOG: An International Journal of Obstetrics and Gynaecology, July 7, 2014    Clinical Article

5 Seafood consumption and umbilical cord blood mercury concentrations in a multiethnic maternal and child health cohort Full Text BMC Pregnancy and Childbirth, July 3, 2014    Free full text    Clinical Article

6 A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis American Journal of Obstetrics and Gynecology, July 2, 2014    Clinical Article

7 Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS Metabolism, July 22, 2014    Clinical Article

8 High-dose vaginal metronidazole for recurrent bacterial vaginosis: A pilot study Journal of Lower Genital Tract Disease, April 3, 2014    Clinical Article

9 Partly replacing meat protein with soy protein alters insulin resistance and blood lipids in postmenopausal women with abdominal obesity The Journal of Nutrition, July 23, 2014    Clinical Article

10 Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: A systematic review BJOG: An International Journal of Obstetrics and Gynaecology, June 5, 2014    Evidence Based Medicine    Review Article

11 The effect of chromium supplementation on polycystic ovary syndrome in adolescents Journal of Pediatric and Adolescent Gynecology , May 30, 2014    Clinical Article

12 Rate of low vitamin D levels in a low-risk obstetric population Journal of Midwifery and Women's Health, July 1, 2014    Clinical Article

13 Soy food and isoflavone intake and endometrial cancer risk: The Japan Public Health Center-based prospective study BJOG: An International Journal of Obstetrics and Gynaecology, June 30, 2014    Clinical Article

14 Oophorectomy and hysterectomy and cancer incidence in the cancer prevention study-II nutrition cohort Obstetrics and Gynecology, June 4, 2014    Clinical Article

15 Physical activity in pregnancy and neonatal body composition: The healthy start study Obstetrics and Gynecology, July 30, 2014    Clinical Article

16 Effects of yoga on arm volume among women with breast cancer related lymphedema: A pilot study Journal of Bodywork & Movement Therapies , July 15, 2014    Clinical Article

17 Mode of delivery in women with class III obesity: Planned cesarean compared to induction of labor American Journal of Obstetrics and Gynecology, July 7, 2014    Clinical Article

18 Vitamin D and menopause-A narrative review Maturitas, June 25, 2014    Review Article

19 Prospective association between red and processed meat intakes and breast cancer risk: modulation by an antioxidant supplementation in the SU.VI.MAX randomized controlled trial International Journal of Epidemiology, July 8, 2014    Clinical Article

20 Association between labetalol use for hypertension in pregnancy and adverse infant outcomes European Journal of Obstetrics & Gynecology and Reproductive Biology, February 17, 2014    Clinical Article

Indexed Journals in Obstetrics & Gynecology: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close